AAAAAA
Results:
1-10
|
Results: 10
Authors:
Crivellari, D
Pagani, O
Veronesi, A
Lombardi, D
Nole, F
Thurlimann, B
Hess, D
Borner, M
Bauer, J
Martinelli, G
Graffeo, R
Sessa, C
Goldhirsch, A
Citation: D. Crivellari et al., High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel, ANN ONCOL, 12(3), 2001, pp. 353-356
Authors:
Pagani, O
Sessa, C
Nole, F
Crivellari, D
Lombardi, D
Thurlimann, B
Hess, D
Borner, M
Bauer, J
Martinelli, G
Graffeo, R
Zucchetti, M
D'Incalci, M
Goldhirsch, A
Citation: O. Pagani et al., Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I-II study, ANN ONCOL, 11(8), 2000, pp. 985-991
Authors:
Tomamichel, M
Jaime, H
Degrate, A
de Jong, J
Pagani, O
Cavalli, F
Sessa, C
Citation: M. Tomamichel et al., Proposing phase I studies: Patients', relatives', nurses' and specialists'perceptions, ANN ONCOL, 11(3), 2000, pp. 289-294
Authors:
Roth, AD
Maibach, R
Martinelli, G
Fazio, N
Aapro, MS
Pagani, O
Morant, R
Borner, MM
Herrmann, R
Honegger, H
Cavalli, F
Alberto, P
Castiglione, M
Goldhirsch, A
Citation: Ad. Roth et al., Docetaxel (Taxotere (R))-cisplatin (TC): An effective drug combination in gastric carcinoma, ANN ONCOL, 11(3), 2000, pp. 301-306
Parathyroid hormone-related protein in metastatic breast cancer induced hypercalcemia: A case report
Authors:
Graffeo, R
Pagani, O
Crivelli, M
Zappa, F
Borella, P
Reiner, M
Goldhirsch, A
Citation: R. Graffeo et al., Parathyroid hormone-related protein in metastatic breast cancer induced hypercalcemia: A case report, ANN ONCOL, 11(1), 2000, pp. 97-100
Authors:
Pagani, O
Sessa, C
Martinelli, G
Crivellari, D
Buonadonna, A
Thurlimann, B
Hess, D
Borner, M
Bauer, J
Zampino, G
Zimatore, M
Graffeo, R
Riva, A
Goldhirsch, A
Citation: O. Pagani et al., Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer, ANN ONCOL, 10(5), 1999, pp. 539-545
Authors:
Ghielmini, M
Pagani, O
de Jong, J
Pampallona, S
Conti, A
Maestroni, G
Sessa, C
Cavalli, F
Citation: M. Ghielmini et al., Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer, BR J CANC, 80(7), 1999, pp. 1058-1061
Authors:
Sessa, C
Minoia, C
Ronchi, A
Zucchetti, M
Bauer, J
Borner, M
de Jong, J
Pagani, O
Renard, J
Weil, C
D'Incalci, M
Citation: C. Sessa et al., Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days, ANN ONCOL, 9(12), 1998, pp. 1315-1322
Authors:
Stupp, R
Bauer, J
Pagani, O
Gerard, B
Cerny, T
Sessa, C
Bastian, G
Sarkany, M
Schlapfer, J
Giroux, B
Leyvraz, S
Citation: R. Stupp et al., Ventricular arrhythmia and torsade de pointe: Dose limiting toxicities of the MDR-modulator S9788 in a phase I trial, ANN ONCOL, 9(11), 1998, pp. 1233-1242
Authors:
Pagani, O
Citation: O. Pagani, Taxoids in combination with epirubicin: The search for improved outcomes in breast cancer, SEMIN ONCOL, 25(5), 1998, pp. 23-26
Risultati:
1-10
|